Physician profile
Deepa Potti
NPI 1144206301
$1,665.59
in general payments reported to CMS, 2019-2025
20 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.84 · 2021: $439 · 2022: $872 · 2024: $184 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventric Diagnostics, INC. | $578.39 | 2022 | |
| Janssen Pharmaceuticals, INC | $270.81 | 2021-2022 | |
| Boston Scientific Corporation | $183.62 | 2024 | |
| Novo Nordisk INC | $127.42 | 2021-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $100.05 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $56.18 | 2022-2025 | Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $54.71 | 2022 | |
| Sanofi-Aventis U.S. LLC | $51.52 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $51.00 | 2021-2025 | Rotateq, Capvaxive, Enflonsia |
| Pfizer INC. | $39.21 | 2019 | |
| Organon LLC | $23.61 | 2022 | |
| Exact Sciences Corporation | $21.56 | 2025 | The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $16.66 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.56 | 2021 | |
| Hologic Sales and Service, LLC | $13.63 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $13.15 | 2021 | |
| Abbvie INC. | $12.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.00 | 2019 | |
| Lilly USA, LLC | $11.99 | 2022 | |
| Amgen INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Potti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.